J
Jennifer L. Schouten
Researcher at National Institutes of Health
Publications - 6
Citations - 5300
Jennifer L. Schouten is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Idazoxan & Temporal cortex. The author has an hindex of 6, co-authored 6 publications receiving 4958 citations.
Papers
More filters
Journal ArticleDOI
Distributed and Overlapping Representations of Faces and Objects in Ventral Temporal Cortex
James V. Haxby,M. Ida Gobbini,Maura L. Furey,Alumit Ishai,Jennifer L. Schouten,Pietro Pietrini +5 more
TL;DR: The functional architecture of the object vision pathway in the human brain was investigated using functional magnetic resonance imaging to measure patterns of response in ventral temporal cortex while subjects viewed faces, cats, five categories of man-made objects, and nonsense pictures, and a distinct pattern of response was found for each stimulus category.
Journal ArticleDOI
Distributed representation of objects in the human ventral visual pathway
TL;DR: It is proposed that the functional architecture of the ventral visual pathway is not a mosaic of category-specific modules but instead is a continuous representation of information about object form that has a highly consistent and orderly topological arrangement.
Journal ArticleDOI
The effect of face inversion on activity in human neural systems for face and object perception.
James V. Haxby,Leslie G. Ungerleider,Vincent P. Clark,Jennifer L. Schouten,Elizabeth Hoffman,Alex Martin +5 more
TL;DR: The results suggest that the failure of face Perception systems with inverted faces leads to the recruitment of processing resources in object perception systems, but this failure is not reflected by altered activity in face perception systems.
Journal ArticleDOI
Gender differences in brain metabolic and plasma catecholamine responses to alpha 2-adrenoceptor blockade.
Mark E. Schmidt,John A. Matochik,David S. Goldstein,Jennifer L. Schouten,Alan J. Zametkin,William Z. Potter +5 more
TL;DR: Women showed global increases in metabolism, whereas males had no global changes and some regional decreases in FDG uptake following idazoxan administration, which suggest gender differences in responses to α2-receptor blockade in brain as well.
Journal ArticleDOI
Responses to α2-adrenoceptor blockade by idazoxan in healthy male and female volunteers
Mark E. Schmidt,Robert C. Risinger,Richard L. Hauger,Jennifer L. Schouten,Michael E. Henry,William Z. Potter +5 more
TL;DR: Both subject age and sex appeared to influence the magnitude of responses and the higher dose of idazoxan produced increases in blood pressure, norepinephrine and growth hormone and slight increases in anxiety.